Human papillomavirus vaccine - GSK
Alternative Names: HPV-16 E7/AS02B vaccine - GSK; Human papillomavirus type 16 E7 protein-based vaccine - GSK; PD-E7/AS02B vaccineLatest Information Update: 02 Aug 2023
At a glance
- Originator GlaxoSmithKline
- Class Cancer vaccines; Papillomavirus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Human papillomavirus infections